Experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus treated with a polylactide carrier releasing linezolid

Surgical Infections

Volumn 12, Issue 2, 2011, Pages 131-135

  Tsiolis, Panagiotis ^a   Giamarellos Bourboulis, Evangelos J ^a   Mavrogenis, Andreas F ^a   Savvidou, Olga ^b   Lallos, Stergios N ^a   Frangia, Konstantina ^c   Lazarettos, Ioannis ^a   Nikolaou, Vassilios ^a   Efstathopoulos, Nikolaos E ^a,d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b THRIASIO GENERAL HOSPITAL   (Greece)

^c SOTIRIA GENERAL HOSPITAL   (Greece)

^d Second Department of Orthopaedics   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; POLYLACTIDE; POLYMERIZED DILACTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CANCELLOUS BONE; CONTROLLED STUDY; DRUG RELEASE; FEMUR; HISTOPATHOLOGY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; RABBIT;

ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; OXAZOLIDINONES; POLYESTERS; RABBITS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 79955761917     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2010.050     Document Type: Article

References (14)

1. Lazarettos J, Efstathopoulos N, Papagelopoulos PJ, et al. A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis. Clin Orthop Relat Res;2004;253-258. (Pubitemid 38787747)
2. Kanellakopoulou K, Galanakis N, Giamarellos-Bourboulis EJ, et al. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. J Antimicrob Chemother 2000;46:311-314. (Pubitemid 30639306)
3. Buchholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 1970;41:511-515.
4. Vercillo M, Patzakis MJ, Holtom P, Zalavras CG. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res 2007;461:40-43. (Pubitemid 47344092)
5. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001;358:1975-1982. (Pubitemid 34072884)
6. Peng GW, Stryd RP, Murata S, et al. Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal 1999;20:65-73. (Pubitemid 29206584)
7. Murakami K, Minamide W, Wada K, et al. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29:2240-2244.
8. Norden CW. Experimental osteomyelitis I: A description of the model. J Infect Dis 1970;122:410-418.
9. Smeltzer MS, Thomas JR, Hickmon SG, et al. Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res 1997;15:414-421. (Pubitemid 27327618)
10. Kanellakopoulou K, Kolia M, Anastassiadis A, et al. Lactic acid polymers as biodegradable carriers of fluoroquinolones: An in vitro study. Antimicrob Agents Chemother 1999;43: 714-716. (Pubitemid 29109551)
11. Kanellakopoulou K, Thivaios GC, Kolia M, et al. Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin. Antimicrob Agents Chemother 2008;52:2335-2339. (Pubitemid 351923071)
12. Gillespie WJ, Allardyce RA. Mechanisms of bone degradation in infection: A review of current hypotheses. Orthopedics 1990;13:407-410. (Pubitemid 20141725)
13. Craig WA. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12. (Pubitemid 28068148)
14. LaPlante KL, Leonard SN, Andes DR, et al. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrob Agents Chemother 2008;52:2156-2162. (Pubitemid 351758553)